Transglutaminases and receptor tyrosine kinases

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Amino Acids

• Publication date

  2011-10-11

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00726-011-1113-xPMID 21986960
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-like growth factor-I:vitronectin complex-induced changes in gene expression effect breast cell survival and migration.

  2011cited by this paper
• The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain.

  2010cited by this paper
• Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer.

  2010cited by this paper
• Transglutaminase down‐regulates the dimerization of epidermal growth factor receptor in rat perivenous and periportal hepatocytes

  2009cited by this paper
• Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis.

  2009cited by this paper
• Genetic and cell biological analysis of integrin outside-in signaling.

  2009cited by this paper
• Transglutaminases and neurodegeneration

  2009cited by this paper
• Transglutaminase 2 Is Needed for the Formation of an Efficient Phagocyte Portal in Macrophages Engulfing Apoptotic Cells1

  2009cited by this paper
• Regulation of Platelet-derived Growth Factor Receptor Function by Integrin-associated Cell Surface Transglutaminase*

  2009cited by this paper
• Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptor.

  2008cited by this paper
• Integrin and Growth Factor Receptor Alliance in Angiogenesis

  2008cited by this paper
• Vitronectin: growth factor complexes hold potential as a wound therapy approach.

  2008cited by this paper
• Biochemical visualization of cell surface molecular clustering in living cells

  2008cited by this paper
• Tissue transglutaminase clusters soluble A-type ephrins into functionally active high molecular weight oligomers.

  2007cited by this paper
• The role of the IGF system in cancer growth and metastasis: overview and recent insights.

  2007cited by this paper
• Chimeric vitronectin:insulin-like growth factor proteins enhance cell growth and migration through co-activation of receptors

  2007cited by this paper
• Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.

  2006cited by this paper
• The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling.

  2006cited by this paper
• The role of tissue transglutaminase in cell-matrix interactions.

  2006cited by this paper
• Insulin-Like Growth Factor I Controls a Mutually Exclusive Association of RACK1 with Protein Phosphatase 2A and β1 Integrin To Promote Cell Migration

  2006cited by this paper
• Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease

  2005cited by this paper
• Interaction between insulin-like growth factor-I receptor and alphaVbeta3 integrin linked signaling pathways: cellular responses to changes in multiple signaling inputs.

  2005cited by this paper
• Molecular Mechanisms Underlying the Proangiogenic Effect of Factor XIII

  2005cited by this paper
• beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.

  2005cited by this paper
• Interaction between Insulin-Like Growth Factor-I Receptor and αVβ3 Integrin Linked Signaling Pathways: Cellular Responses to Changes in Multiple Signaling Inputs

  2005cited by this paper
• Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche.

  2004cited by this paper
• Alpha1B-adrenoceptor signaling and cell motility: GTPase function of Gh/transglutaminase 2 inhibits cell migration through interaction with cytoplasmic tail of integrin alpha subunits.

  2004cited by this paper
• Augmentation of Tissue Transglutaminase Expression and Activation by Epidermal Growth Factor Inhibit Doxorubicin-induced Apoptosis in Human Breast Cancer Cells*

  2004cited by this paper
• α1B-Adrenoceptor Signaling and Cell Motility

  2004cited by this paper
• Transglutaminases: crosslinking enzymes with pleiotropic functions

  2003cited by this paper
• Activation of the Ras-ERK Pathway Inhibits Retinoic Acid-induced Stimulation of Tissue Transglutaminase Expression in NIH3T3 Cells*

  2003cited by this paper
• Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.

  2003cited by this paper
• Transglutaminase 2: an enigmatic enzyme with diverse functions.

  2002cited by this paper
• Integrins in development: moving on, responding to, and sticking to the extracellular matrix.

  2002cited by this paper
• Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFbeta-dependent matrix deposition.

  2001cited by this paper
• The protein tyrosine kinase family of the human genome

  2000cited by this paper
• Tissue Transglutaminase Is an Integrin-Binding Adhesion Coreceptor for Fibronectin

  2000cited by this paper
• Eph receptors and ephrins: effectors of morphogenesis.

  1999cited by this paper
• Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion‐dependent cell survival

  1998cited by this paper
• Transglutaminase-catalyzed Cross-linking of Osteopontin Is Inhibited by Osteocalcin*

  1997cited by this paper
• αvβ3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF

  1997cited by this paper
• Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF.

  1997cited by this paper
• α6β4 and α6β1 Integrins Associate with ErbB-2 in Human Carcinoma Cell Lines

  1997cited by this paper
• Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines.

  1997cited by this paper
• The Roles of Integrins and Extracellular Matrix Proteins in the Insulin-like Growth Factor I-stimulated Chemotaxis of Human Breast Cancer Cells (*)

  1996cited by this paper
• Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells.

  1995cited by this paper
• Association of insulin receptor substrate-1 with integrins.

  1994cited by this paper
• Visualization of purified fibronectin-transglutaminase complexes.

  1992cited by this paper
• Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization.

  1991cited by this paper
• Vitronectin is a substrate for transglutaminases.

  1988cited by this paper
• Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen.

  1987cited by this paper

• Effects of Laccase and Transglutaminase on the Physicochemical and Functional Properties of Hybrid Lupin and Whey Protein Powder

  2024cites this paper
• Protein kinases involved in epidermal barrier formation: The AKT family and other animals

  2018cites this paper
• The dynamic nature of transglutaminases

  2018cites this paper
• Modulation of transglutaminase 2 by the A1 adenosine receptor and β2-adrenoceptor in cardiomyoblasts: a role in cell survival

  2017cites this paper
• factor:extracellular matrix (GF:ECM) interactions for the management of breast cancer. Insulin-like growth factor-I (IGF-I) forms multi-protein complexes with IGF-binding proteins (IGFBP) and the ECM protein vitronectin (VN), and stimulates the survival, migration and invasion of breast cancer

  2016cites this paper
• Antagonists of IGF:Vitronectin Interactions Inhibit IGF-I–Induced Breast Cancer Cell Functions

  2016cites this paper
• Celiac Anti-Type 2 Transglutaminase Antibodies Induce Phosphoproteome Modification in Intestinal Epithelial Caco-2 Cells

  2013cites this paper
• Lysine residues of IGF-I are substrates for transglutaminases and modulate downstream IGF-I signalling.

  2013cites this paper
• Vitronectin—Master controller or micromanager?

  2013cites this paper
• PEGylation of lysine residues reduces the pro-migratory activity of IGF-I.

  2013cites this paper
• Transglutaminases: future perspectives

  2012cites this paper